Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 46

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

194

HTML

1561

Figures (1-2)

168

Tables (1-5)

139

Sum=2062

Dec 14, 2007 (publication date) through Apr 24, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Dec 14, 2007; 13(46): 6236-6242
Published online Dec 14, 2007. doi: 10.3748/wjg.v13.i46.6236

Table 1 Primer sequences used to amplify ISDR and PePHD

Region	Primer direction	Sequence (5’ to 3’)	Nucleotide No
ISDR	Outer sense	TGGATGGAGTGCGGTTGCACAGGTA	6703-6727
	Outer antisense	TGTAAAACGACGGCCAG	7296-7320
	Inner sense	TCTTTCTCCGTGGAGGTGGTATTGC	6722-6741
	Inner antisense	CAGGAAACAGCTATGACC	7275-7294
PePHD	Outer sense	TGACTACCCATACAGGCTCT	2180-2199
	Outer antisense	AAGGAAGGAGAGATTGCCAT	2725-2744
	Inner sense	AAGGTTAGGATGTATGTGGG	2238-2257
	Inner antisense	ATTGAGGACCACCGAGTTCT	2689-2708

ISDR: Interferon sensitivity determining region; PePHD: PKR-eIF2α phosphorylation homology domain; PKR: RNA-activated protein kinase.

Citation: Yoon J, Lee JI, Baik SK, Lee KH, Sohn JH, Lee HW, Namkung J, Chang SJ, Choi JW, Kim HW, Yeh BI. Predictive factors for interferon and ribavirin combination therapy in patients with chronic hepatitis C. World J Gastroenterol 2007; 13(46): 6236-6242
URL: https://www.wjgnet.com/1007-9327/full/v13/i46/6236.htm
DOI: https://dx.doi.org/10.3748/wjg.v13.i46.6236